(XSOE) Emerging Markets - Overview
Etf: Emerging, Market, Stocks, Non-State-Owned
Dividends
| Dividend Yield | 1.58% |
| Yield on Cost 5y | 1.46% |
| Yield CAGR 5y | 3.94% |
| Payout Consistency | 82.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 17.0% |
| Relative Tail Risk | -0.83% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.70 |
| Alpha | 26.76 |
| Character TTM | |
|---|---|
| Beta | 0.677 |
| Beta Downside | 0.661 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.96% |
| CAGR/Max DD | 0.81 |
Description: XSOE Emerging Markets January 14, 2026
The WisdomTree Emerging Markets ex-State-Owned Enterprises Fund (NYSE ARCA:XSOE) aims to allocate at least 80 % of its assets to securities that mirror the composition of its underlying index, which is a float-adjusted, market-cap-weighted basket of common stocks from emerging markets that explicitly excludes state-owned enterprises. Because the fund is classified as non-diversified, a relatively concentrated exposure to its top holdings is permissible under SEC rules.
As of the most recent filing (Q4 2025), XSOE reported an expense ratio of roughly 0.65 % and total net assets near $1.2 billion. The portfolio is heavily weighted toward technology (≈30 % of assets) and consumer discretionary (≈20 %), with Taiwan Semiconductor Manufacturing Co. and MercadoLibre being among the top ten constituents. Key macro drivers for the fund include sustained demand for semiconductors in Asia, rising middle-class consumption in India and Brazil, and the gradual fiscal de-leveraging of non-state enterprises, which tends to improve corporate earnings visibility in these markets.
For a deeper, data-driven analysis of XSOE’s risk-adjusted performance and sector tilt, you might explore the fund’s profile on ValueRay, where granular metrics and scenario modeling are readily available.
What is the price of XSOE shares?
Over the past week, the price has changed by +1.49%, over one month by +3.62%, over three months by +9.83% and over the past year by +38.19%.
Is XSOE a buy, sell or hold?
What are the forecasts/targets for the XSOE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 46.3 | 9.4% |
XSOE Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.89b USD (1.89b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.89b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.89b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.41% (E(1.89b)/V(1.89b) * Re(8.41%) + (debt-free company))
Discount Rate = 8.41% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)